BORDONI, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 403
EU - Europa 223
AS - Asia 120
AF - Africa 3
Totale 749
Nazione #
US - Stati Uniti d'America 401
IE - Irlanda 92
HK - Hong Kong 82
IT - Italia 75
VN - Vietnam 21
CN - Cina 13
BE - Belgio 10
DE - Germania 10
FR - Francia 10
RU - Federazione Russa 7
FI - Finlandia 5
NL - Olanda 4
AT - Austria 2
CA - Canada 2
CI - Costa d'Avorio 2
GB - Regno Unito 2
SE - Svezia 2
UA - Ucraina 2
UZ - Uzbekistan 2
EE - Estonia 1
IR - Iran 1
LB - Libano 1
MA - Marocco 1
RO - Romania 1
Totale 749
Città #
Chandler 130
Dublin 88
Hong Kong 82
Ann Arbor 34
Perugia 30
San Mateo 28
Dong Ket 21
Medford 16
Princeton 16
Altamura 15
Brussels 10
Lawrence 10
Wilmington 10
Redwood City 9
Ashburn 7
Los Angeles 7
Beijing 6
Andover 5
Saint Petersburg 5
Den Haag 4
Florence 4
Cambridge 3
Des Moines 3
Houston 3
Lappeenranta 3
Abidjan 2
Bologna 2
Dearborn 2
Helsinki 2
Menlo Park 2
Naples 2
Norwalk 2
Redmond 2
San Diego 2
Toronto 2
Vienna 2
Avignon 1
Boydton 1
Castiglione del Lago 1
Cava Dei Tirreni 1
Cormeilles-en-Parisis 1
Esslingen am Neckar 1
Frankfurt am Main 1
Fremont 1
Harbin 1
Hefei 1
Jacksonville 1
Jinan 1
Magdeburg 1
Nanjing 1
Philadelphia 1
Rabat 1
Radeberg 1
San Paolo di Civitate 1
Seattle 1
Tallinn 1
Tenhult 1
Timisoara 1
Woodbridge 1
Zanjan 1
Totale 595
Nome #
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 69
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 54
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 51
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 48
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 46
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 42
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 40
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 37
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 36
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 34
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 32
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 32
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 32
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 28
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 28
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 26
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 24
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 22
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 22
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 21
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 19
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 17
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 14
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 8
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 6
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 5
Totale 793
Categoria #
all - tutte 3.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 7 0
2019/202038 0 2 1 0 1 4 7 3 5 7 6 2
2020/202184 6 0 3 3 23 9 6 3 0 7 2 22
2021/2022129 4 23 1 5 1 1 13 24 2 16 13 26
2022/2023388 27 60 4 32 39 43 0 17 143 1 14 8
2023/2024147 8 17 3 5 12 1 51 26 17 7 0 0
Totale 793